# Equatorial Guinea Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Equatorial Guinea HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Equatorial Guinea (GNQ)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $224.3M
- Products: 83
- Buyer markets: 17
- Average CAGR: +6.5%
- Global sector size: $29.6B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $13.4B | $99.4K | $5.6B | +14.8% | 4 | +0.0% |
| HS 290110 - Acyclic hydrocarbons: saturated | $1.1B | $172.9K | $1.5B | +14.1% | 2 | +0.0% |
| HS 290511 - Alcohols: saturated monohydric, methanol (methyl alcohol) | $3.8B | $220.2M | $1.5B | +25.1% | 10 | +5.9% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $2.4B | $1.0K | $1.2B | +15.1% | 3 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $1.6B | $1.5K | $1.1B | -52.7% | 2 | +0.0% |
| HS 293379 - Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) | $1.3B | $1.5M | $751.0M | +27.0% | 1 | +0.1% |
| HS 293329 - Heterocyclic compounds: containing an unfused imidazole ring (whether or not hydrogenated) in the structure, other than hydantoin and its derivatives | $201.4M | $99.3K | $178.1M | -4.1% | 1 | +0.0% |
| HS 293339 - Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts, other than piperidine and its salts | $238.8M | $65.0K | $163.0M | +0.5% | 1 | +0.0% |
| HS 293349 - Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused, other than levorphanol (INN) and its salts | $135.9M | $11.6K | $151.9M | -5.4% | 1 | +0.0% |
| HS 293359 - Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | $375.3M | $155.7K | $126.4M | +3.9% | 1 | +0.0% |
| HS 293331 - Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, pyridine and its salts | $67.8M | $27.9K | $93.1M | +6.3% | 1 | +0.0% |
| HS 290220 - Cyclic hydrocarbons: benzene | $154.8M | $46.8K | $88.7M | +4.8% | 1 | +0.0% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $392.4M | $193.0K | $84.7M | -2.8% | 1 | +0.0% |
| HS 290321 - Unsaturated chlorinated derivatives of acyclic hydrocarbons: vinyl chloride (chloroethylene) | $78.2M | $818.9 | $84.4M | -10.9% | 1 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $244.3M | $76.3 | $80.9M | -10.4% | 1 | +0.0% |
| HS 291736 - Acids: aromatic polycarboxylic acids: terephthalic acid and its salts | $80.6M | $53.5K | $77.3M | +2.7% | 1 | +0.1% |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $113.3M | $96.7K | $69.3M | +65.3% | 1 | +0.1% |
| HS 290339 - Fluorinated, brominated or iodinated derivatives of acyclic hydrocarbons: other than ethylene dibromide (ISO) (1,2-dibromoethane) | $160.2M | $59.2K | $68.3M | +4.1% | 1 | +0.0% |
| HS 340319 - Lubricating preparations: (other than for the treatment of textile and similar materials), containing less than 70% (by weight) of petroleum oils or oils obtained from bituminous minerals | $141.0M | $225.1 | $68.0M | +33.3% | 1 | +0.0% |
| HS 292429 - Cyclic amides (including cyclic carbamates) and their derivatives: other than the derivatives and salts of ureines, 2-acetamidobenzoic acid (N-acetylanthancillic acid), and ethinamate S | $124.5M | $76.9K | $65.3M | +1.9% | 1 | +0.1% |
| HS 340399 - Lubricating preparations: other than for the treatment of textile and similar materials, not containing petroleum oils or oils obtained from bituminous minerals | $204.7M | $757.6 | $63.6M | +11.1% | 2 | +0.0% |
| HS 293399 - Heterocyclic compounds: n.e.c. in headings no. 2933 | $185.4M | $258.3K | $62.4M | +2.3% | 1 | +0.1% |
| HS 294110 - Antibiotics: penicillins and their derivatives with a penicillanic acid structure: salts thereof | $85.8M | $31.5K | $57.1M | +0.0% | 1 | +0.0% |
| HS 300190 - Glands and other organs: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, n.e.c. in heading 3001 | $205.3M | $76.6 | $53.9M | -21.8% | 1 | +0.0% |
| HS 321410 - Mastics: painters' fillings | $89.3M | $233.2 | $52.4M | +3.9% | 1 | +0.0% |
| HS 290531 - Alcohols: acyclic, diols: ethylene glycol (ethanediol) | $57.0M | $19.5K | $51.1M | -2.5% | 1 | +0.0% |
| HS 340120 - Soap: in forms n.e.c. in item no. 3401.11 | $33.8M | $4.6K | $44.2M | +186.0% | 1 | +0.1% |
| HS 291899 - Acids: carboxylic acids, with additional oxygen function (not alcohol, phenol, aldehyde or ketone) and their anhydrides, halides, peroxides and peroxyacids: their halogenated, sulphonated, nitrated or nitrosated derivatives: other than 2,4,5-T (ISO) | $55.2M | $29.2K | $43.5M | -0.4% | 1 | +0.1% |
| HS 320611 - Colouring matter: pigments and preparations based on titanium dioxide, containing 80% or more by weight of titanium dioxide calculated on the dry matter | $40.5M | $342.3 | $41.2M | -3.4% | 1 | +0.0% |
| HS 293722 - Steroidal hormones, their derivatives and structural analogues: halogenated derivatives of corticosteroidal hormones | $56.9M | $21.7K | $40.9M | +3.0% | 1 | +0.0% |
| HS 293719 - Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts | $51.1M | $63.5K | $40.6M | +14.3% | 1 | +0.1% |
| HS 293979 - Alkaloids: of vegetal origin, other than cocaine, ecgonine: salts, esters and other derivatives: n.e.c. in heading no. 2939 | $49.0M | $12.3K | $34.9M | +16.5% | 1 | +0.0% |
| HS 293090 - Organo-sulphur compounds: n.e.s. in heading no. 2930 | $83.9M | $32.4K | $34.3M | +24.6% | 1 | +0.0% |
| HS 290545 - Alcohols: polyhydric, glycerol | $64.5M | $44.2K | $33.1M | +3.3% | 1 | +0.1% |
| HS 294190 - Antibiotics: n.e.c. in heading no. 2941 | $100.8M | $75.2K | $30.7M | -4.4% | 1 | +0.1% |
| HS 293220 - Heterocyclic compounds: with oxygen hetero-atom(s) only, containing an unfused furan ring (whether or not hydrogenated) in the structure, lactones | $76.7M | $25.5K | $29.7M | -11.6% | 1 | +0.0% |
| HS 292610 - Nitrile-function compounds: acrylonitrile | $51.1M | $13.2K | $29.5M | -1.3% | 1 | +0.0% |
| HS 292249 - Amino-acids, other than those containing more than one kind of oxygen function, their esters: salts thereof, excluding lysine, glutamic acid, anthranalic acid and tilidine, their esters and salts thereof | $70.8M | $36.4K | $27.7M | -0.1% | 1 | +0.1% |
| HS 292529 - Imines and their derivatives: salts thereof: other than chlordimeform (ISO) | $46.7M | $20.8K | $27.6M | +6.6% | 1 | +0.0% |
| HS 293134 - Organo-inorganic compounds: organo-phosphorus derivatives, sodium-3-(hydroxysilyl)propyl methylphosphonate | $28.1M | $14.6K | $27.4M | +5.3% | 1 | +0.1% |
| HS 291612 - Acids: unsaturated acyclic monocarboxylic acids: esters of acrylic acid | $80.7M | $37.4K | $26.3M | -2.4% | 1 | +0.0% |
| HS 291590 - Acids: saturated acyclic monocarboxylic acids: anhydrides, halides, peroxides, peroxyacids and halogenated, sulphonated, nitrated or nitrosated derivatives, n.e.c. in heading no. 2915 | $113.5M | $39.6K | $24.1M | -3.3% | 1 | +0.0% |
| HS 293190 - Organo-inorganic compounds: other than tetramethyl lead, tetraethyl lead, and tributyltin compounds | $64.7M | $29.8K | $24.1M | +8.6% | 1 | +0.0% |
| HS 293214 - Heterocyclic compounds: with oxygen hetero-atom(s) only, containing an unfused furan ring (whether or not hydrogenated) in the structure, sucralose | $20.8M | $14.3K | $23.9M | +0.9% | 1 | +0.1% |
| HS 292320 - Lecithins and other phosphoaminolipids, whether or not chemically defined | $50.2M | $17.1K | $23.9M | +3.2% | 1 | +0.0% |
| HS 290712 - Monophenols: cresols and their salts | $33.3M | $15.1K | $23.6M | -1.2% | 1 | +0.0% |
| HS 292241 - Amino-acids: their esters, (other than those containing more than one kind of oxygen function), lysine and its esters: salts thereof | $57.5M | $19.6K | $23.2M | +2.2% | 1 | +0.0% |
| HS 380891 - Insecticides: not containing substances of 3808.50: put up in forms or packings for retail sale or as preparations or articles | $31.8M | $2.1K | $23.2M | +3.8% | 1 | +0.0% |
| HS 292419 - Acyclic amides (including acyclic carbamates) and their derivatives: salts thereof, other than meprobamate (INN), fluoroacetamide (ISO), monocrotophos (ISO) or phosphamidon (ISO) | $74.3M | $36.8K | $23.1M | +5.7% | 1 | +0.0% |
| HS 291733 - Acids: aromatic polycarboxylic acids: dinonyl or didecyl orthophthalates | $29.4M | $14.6K | $22.9M | +6.0% | 1 | +0.0% |
| HS 291422 - Ketones: cyclanic, cyclenic or cycloterpenic, without other oxygen function, cyclohexanone and methylcyclohexanones | $37.8M | $4.8K | $22.7M | +2.7% | 1 | +0.0% |
| HS 293911 - Alkaloids, vegetable: of opium and their derivatives: salts thereof | $41.9M | $11.5K | $21.7M | +2.0% | 1 | +0.0% |
| HS 293299 - Heterocyclic compounds: with oxygen hetero-atom(s) only, no lactones or unfused furan rings (hydrogenated or not) in the structure, other than isosafrole, 1-(1,3-benzodiaxol-5-yl) propan-2-one, piperonal, safrole, tetrahydrocannabinols (all isomers) | $69.2M | $27.2K | $21.5M | -3.8% | 1 | +0.0% |
| HS 291814 - Acids: carboxylic acids, (with alcohol function but without other oxygen function), citric acid | $49.4M | $20.4K | $21.3M | +1.5% | 1 | +0.0% |
| HS 292219 - Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters: salts thereof, n.e.c. in item no. 2922.1 | $45.1M | $23.5K | $20.4M | -2.1% | 1 | +0.1% |
| HS 290949 - Ether-alcohols and their halogenated, sulphonated, nitrated or nitrosated derivatives: n.e.s. in item no. 2909.4 | $73.1M | $32.2K | $19.7M | -0.6% | 1 | +0.0% |
| HS 290519 - Alcohols: saturated monohydric, n.e.s. in item no. 2905.1 | $26.7M | $5.9K | $19.5M | -3.5% | 1 | +0.0% |
| HS 290711 - Monophenols: phenol (hydroxybenzene) and its salts | $45.3M | $15.1K | $18.9M | -4.5% | 1 | +0.0% |
| HS 292090 - Esters of inorganic acids (excluding esters of hydrogen halides) and their salts, their halogenated, sulphonated, nitrated or nitrosated derivatives, n.e.s. in heading no. 2920 | $41.3M | $20.3K | $18.9M | +5.9% | 1 | +0.0% |
| HS 293040 - Organo-sulphur compounds: methionine | $34.6M | $3.9K | $18.7M | +6.9% | 1 | +0.0% |
| HS 290129 - Acyclic hydrocarbons: unsaturated, n.e.s. in heading no. 2901 | $34.9M | $10.4K | $18.2M | -0.4% | 1 | +0.0% |
| HS 290919 - Ethers: acyclic, and their halogenated, sulphonated, nitrated or nitrosated derivatives, other than diethyl ether | $29.3M | $15.3K | $17.9M | -5.5% | 1 | +0.1% |
| HS 291532 - Acids: saturated acyclic monocarboxylic acids: vinyl acetate | $39.8M | $14.2K | $17.8M | +0.4% | 1 | +0.0% |
| HS 291479 - Ketones and quinones: halogenated, sulphonated, nitrated or nitrosated derivatives, other than chlordecone (ISO) | $26.0M | $18.8K | $17.8M | +8.4% | 1 | +0.1% |
| HS 290331 - Fluorinated, brominated or iodinated derivatives of acyclic hydrocarbons: ethylene dibromide (ISO) (1,2-dibromoethane) | $16.3M | $6.6K | $17.3M | -5.4% | 1 | +0.0% |
| HS 290532 - Alcohols: acyclic, diols: propylene glycol (propane-1, 2-diol) | $39.4M | $23.5K | $17.2M | -1.2% | 1 | +0.1% |
| HS 292250 - Amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function | $56.7M | $84.2K | $16.8M | -3.6% | 1 | +0.1% |
| HS 290311 - Saturated chlorinated derivatives of acyclic hydrocarbons: chloromethane (methyl chloride) and chloroethane (ethyl chloride) | $15.9M | $7.6K | $16.5M | +0.3% | 1 | +0.0% |
| HS 291819 - Acids: carboxylic acids, (with alcohol function but without other oxygen function), other than lactic, tartaric, citric, and gluconic acids and their salts and esters | $44.7M | $17.0K | $16.3M | +3.5% | 1 | +0.0% |
| HS 292390 - Quaternary ammonium salts and hydroxides: whether or not chemically defined n.e.c. in heading no. 2923 | $42.2M | $16.7K | $16.2M | +4.2% | 1 | +0.0% |
| HS 290250 - Cyclic hydrocarbons: styrene | $30.0M | $17.2K | $15.9M | -8.7% | 1 | +0.1% |
| HS 290122 - Acyclic hydrocarbons: unsaturated, propene (propylene) | $39.4M | $15.2K | $15.6M | -2.9% | 1 | +0.0% |
| HS 291611 - Acids: unsaturated acyclic monocarboxylic acids: acrylic acid and its salts | $25.6M | $13.3K | $15.6M | -5.0% | 1 | +0.1% |
| HS 290543 - Alcohols: polyhydric, mannitol | $14.3M | $5.1K | $15.4M | +17.3% | 1 | +0.0% |
| HS 292910 - Nitrogen-function compounds: n.e.c. in chapter 29, isocyanates | $50.7M | $25.9K | $15.1M | -4.3% | 1 | +0.1% |
| HS 293627 - Vitamins: vitamin C and its derivatives, unmixed | $39.6M | $11.8K | $14.5M | -2.2% | 1 | +0.0% |
| HS 290542 - Alcohols: polyhydric, pentaerythritol | $16.4M | $5.8K | $14.4M | +5.9% | 1 | +0.0% |
| HS 293629 - Vitamins: n.e.c. in item no. 2936.2, and their derivatives, unmixed | $43.6M | $17.4K | $14.0M | -1.5% | 1 | +0.0% |
| HS 294000 - Sugars, chemically pure, other than sucrose, lactose, maltose, glucose and fructose: sugar ethers, sugar acetals and sugar esters, and their salts, other than the products of heading 29.37, 29.38, or 29.39 | $30.8M | $17.5K | $13.9M | +0.3% | 1 | +0.1% |
| HS 293628 - Vitamins: vitamin E and its derivatives, unmixed | $43.6M | $12.3K | $13.8M | -3.1% | 1 | +0.0% |
| HS 291411 - Ketones: acyclic, without other oxygen function, acetone | $22.2M | $1.7K | $13.5M | -12.1% | 1 | +0.0% |
| HS 293890 - Glycosides: natural or reproduced by synthesis, other than rutoside (rutin) and its derivatives | $26.5M | $12.4K | $13.4M | +2.8% | 1 | +0.0% |
| HS 293361 - Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, melamine | $26.3M | $10.0K | $13.2M | +0.1% | 1 | +0.0% |

## Best markets

- China (CHN): $4.1B calculated opportunity across 1 products.
- United Kingdom (GBR): $3.7B calculated opportunity across 71 products.
- France (FRA): $2.3B calculated opportunity across 4 products.
- USA, Puerto Rico and US Virgin Islands (USA): $1.4B calculated opportunity across 2 products.
- Canada (CAN): $1.1B calculated opportunity across 2 products.
- Netherlands (NLD): $409.8M calculated opportunity across 3 products.
- Germany (DEU): $245.6M calculated opportunity across 1 products.
- Belgium (BEL): $228.8M calculated opportunity across 1 products.
- Spain (ESP): $210.4M calculated opportunity across 4 products.
- Brazil (BRA): $208.5M calculated opportunity across 1 products.
- Czechia (CZE): $177.0M calculated opportunity across 1 products.
- South Africa (ZAF): $166.7M calculated opportunity across 1 products.

## Growth stars

- HS 340120: +186.0% average CAGR, $44.2M calculated opportunity.
- HS 300490: +65.3% average CAGR, $69.3M calculated opportunity.
- HS 340319: +33.3% average CAGR, $68.0M calculated opportunity.
- HS 293379: +27.0% average CAGR, $751.0M calculated opportunity.
- HS 290511: +25.1% average CAGR, $1.5B calculated opportunity.
- HS 293090: +24.6% average CAGR, $34.3M calculated opportunity.
- HS 290543: +17.3% average CAGR, $15.4M calculated opportunity.
- HS 293979: +16.5% average CAGR, $34.9M calculated opportunity.
- HS 382200: +15.1% average CAGR, $1.2B calculated opportunity.
- HS 330499: +14.8% average CAGR, $5.6B calculated opportunity.

## Diversification opportunities

- HS 290511: 10 buyer markets, $1.5B calculated opportunity.
- HS 330499: 4 buyer markets, $5.6B calculated opportunity.
- HS 382200: 3 buyer markets, $1.2B calculated opportunity.
- HS 290110: 2 buyer markets, $1.5B calculated opportunity.
- HS 382499: 2 buyer markets, $1.1B calculated opportunity.
- HS 340399: 2 buyer markets, $63.6M calculated opportunity.
- HS 293379: 1 buyer markets, $751.0M calculated opportunity.
- HS 293329: 1 buyer markets, $178.1M calculated opportunity.
- HS 293339: 1 buyer markets, $163.0M calculated opportunity.
- HS 293349: 1 buyer markets, $151.9M calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.